# Innatrix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/innatrix

- Industry: Biotechnology
- Headquarters: Durham, US
- Website: www.innatrix.com
- Latest round: Seed (Mar 10, 2022)
- Investors on record: 1

## About

Based in NC, US, and founded in 2013 by John Salmeron, Innatrix Inc. develops biological and chemical treatments using patented protein evolution technology to control untreatable crop diseases, pests, and weeds. In March 2022, Innatrix raised Seed funding from SOSV. As of 2022, Jiarui Li is the CEO of the company.

The company is developing EvoStat™, which is an automated platform for protein engineering via continuous laboratory evolution or other approaches such as phage display or SIP-phage display. The EvoStat™ provides advanced control, reporting, recording, simulation, and remote access and is available for plotting and analysis.

The firm's other products in the pipeline include InnaLB™ (potato late blight), InnaNema™ (soybean cyst nematode), and InnaHLB™ (citrus greening). Innatrix's services include specialties, biological products, chemical research, eco-friendly products, and modern technology.

## Funding rounds

- Seed, Mar 10, 2022 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed